Company intelligence / Profile preview

CastleVax

New York, New York, United Statescastlevax.com ↗

Ownership: Private
Development stage: Phase 2

Overview

CastleVax’s NDV-vectored intranasal COVID‑19 vaccine has demonstrated an attractive safety profile and low reactogenicity in several completed and ongoing phase 1, 2, and 3 clinical trials. The live version delivered intranasally, as well as an inactivated version delivered intramuscularly, have both reached advanced clinical stages with Emergency Use Authorization granted in Mexico and Thailand.

Therapeutic areas: PulmonologyInfectious Diseases
Modalities: Live attenuated viral vectors (NDV-based)Inactivated vaccinesGenetically engineered subunit vaccinesProphylactic vaccines
Industry: Biotech

Drug pipeline

5 assets

NDV-HXP-S-KP.2

4 more assets in the full pipeline.

Request access →

Partnerships

BARDA/Project NextGenMicron Biomedical/CEPI collaboration on needle-free delivery technologymanufacturing partners in Brazil, Mexico, Vietnam, Thailand for global production scale-up

Beyond the preview

Go deeper on CastleVax.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CastleVax.

Explore the full profile